The purpose of this retrospective study was to determine whether RFA could provide an alternative treatment modality for selected patients who are not candidates for hepatic resection.
A total of 18 consecutive patients with liver metastases alone from gastric cancer treated with radiofrequency ablation (RFA, n = 11) or hepatic resection (HR, n = 7) at Seoul St. Mary’s Hospital, Korea, between January 2000 and September 2014, were enrolled.
The median OS and DFS in the RFA group were 40.5 ± 22.3 and 10.3 ± 1.07 months, respectively. There was no significant difference between the RFA and HR groups in terms of baseline characteristics except for performance status. Mean survival and DFS times of all patients were 60.1 ± 9.4 and 40.9 ± 10.2 months, respectively. Mean OS times in the HR and RFA groups were 67.5 ± 15.4 and 51.1 ± 9.8 months (P = 0.671), respectively, and the mean DFS time in the HR group (74.1 ± 14.2 months) was longer than that in the RFA group (26.9 ± 9.2 months), but the difference was not significant (P = 0.076).
In patients who are not candidates for surgical treatment, RFA may be an alternative to HR.
Dittmar Y, Altendorf-Hofmann A, Rauchfuss F, et al. Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2012;15(2):131–6.
Chen J, Tang Z, Dong X, et al. Radiofrequency ablation for liver metastasis from gastric cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2013;39(7):701–6.
Kim HR, Cheon SH, Lee K-H, et al. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2010;26(4):305–15. CrossRef
Ahmad A, Chen SL, Kavanagh MA, et al. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg. 2006;72(10):875–9. PubMed
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 1998;1(1):10–24.
Jerraya H, Saidani A, Khalfallah M, et al. Management of liver metastases from gastric carcinoma: where is the evidence? Tunis Med. 2013;91(1):1–5. PubMed
Cheon SH, Rha SY, Jeung H-C, et al. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2008;19(6):1146–53. CrossRef
Takemura N, Saiura A, Koga R, et al. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg Dtsch Ges Fur Chir. 2012;397(6):951–7. CrossRef
Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg Chic Ill. 2001;136(8):864–9. CrossRef
Zacherl J, Zacherl M, Scheuba C, et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2002;6(5):682–9. CrossRef
Roh HR, Suh K-S, Lee H-J, et al. Outcome of hepatic resection for metastatic gastric cancer. Am Surg. 2005;71(2):95–9. PubMed
- Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection
Jin Won Lee
Moon Hyung Choi
Young Joon Lee
Han Mo Yoo
Kyo Young Song
Cho Hyun Park
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II